Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05805722 · ClinicalTrials.gov registry record · NA

Comprehensive Tobacco Cessation for Cancer Patients and Survivors

A NA study of Cancer and Tobacco Use Cessation, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05805722 is a NA study of Cancer and Tobacco Use Cessation that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 75 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05805722, a NA study of Cancer and Tobacco Use Cessation, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to learn how best to incorporate tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers.

Interventions

  • BEHAVIORAL Behavioral counseling for tobacco cessation

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2023-04-12
Est. Completion 2027-09-30
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05805722

The ClinicalTrials.gov registry entry for NCT05805722 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Behavioral counseling for tobacco cessation is the first listed.

NCT05805722 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT05805722 about?

NCT05805722 is a clinical study titled "Comprehensive Tobacco Cessation for Cancer Patients and Survivors". The purpose of this research study is to learn how best to incorporate tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers.

What is the current status of trial NCT05805722?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2023-04-12. Estimated completion is 2027-09-30.

What conditions does trial NCT05805722 study?

This clinical trial studies the following conditions: Cancer, Tobacco Use Cessation.

What interventions are being tested in trial NCT05805722?

The interventions under investigation include: Behavioral counseling for tobacco cessation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05805722?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05805722 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.